Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

Author: Hubbard Joleen   Erlichman Charles   Toft David   Qin Rui   Stensgard Bridget   Felten Sara   Ten Eyck Cynthia   Batzel Gretchen   Ivy S.   Haluska Paul  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.29, Iss.3, 2011-06, pp. : 473-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content